Expert regulatory guidance for a faster path to drug product approval.

We support pharmaceutical and biotech innovators seeking product approvals in major global markets.

CMC

Guided by former
CMC regulators.

Learn More

Preclinical

From study design to
report writing & review.

Learn More

Clinical

To streamline the
path to approval.

Learn More

Post-Approval

Lifecycle strategies for
marketed products.

Learn More

What products are you looking to bring to market?

We deliver deep real-world global regulatory affairs expertise and hands-on support for:

JOIN US FOR
2020 AAPS PharmSci 360

October 26 – November 3
Explore virtual sessions & schedule a 1-on-1 with the DataRevive team.

Register Now

A full-service partner for the entire product development lifecycle.

Team Wayne Hutman

Managing Director

H. Wayne Hutman, M.D.

  • 20+ years in pharma industry
  • Has conducted 100+ clinical trials
Team Julia Carrier

Vice President Non-Clinical

Julia Carrier, Ph.D.

  • Formerly of Pfizer
  • 18+ years in nonclinical PD, PK, and toxicology

Team Yong Wang

Vice President CMC Small Molecule

Yong Wang, Ph.D.

  • Formerly of FDA CDER
  • 17+ years of experience
Michele Dougherty

Vice President CMC Biologics

Michele Dougherty, Ph.D.

  • Formerly FDA CDER OBP Review Chief
  • 17+ years of experience

Monica Hughes

Vice President Regulatory & Project Management

Monica Hughes, M.S.

  • Formerly of FDA CDER
  • 17+ years of experience
Audrey Jia

Regulatory & CMC Principal Consultant

Audrey Jia, M.D., Ph.D.

  • Formerly of FDA CDER & Pfizer
  • 20+ years of experience

Make our specialists an extension of your team.

No other consulting firm maintains the depth and breadth of expertise that DataRevive has in-house. Tap it today!

Start Here

5 Gmp Inspections
Did You Know?

In one year, DataRevive completed 5 GMP pre-approval inspections for small molecule & biological products in Japan, China, Scandinavia, and the US.

View Case Studies

May 1, 2020

Resuming Business Operations Following the COVID-19 Pandemic: Part Two

Read Blog Post

May 7, 2020

Avoiding and Reacting To Human Tissue, Cell And Gene Therapy Enforcement Actions: Communication Is Key

Read Blog Post